These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29325847)

  • 1. Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia.
    Frankle WG; Paris J; Himes M; Mason NS; Mathis CA; Narendran R
    Biol Psychiatry; 2018 Apr; 83(8):707-714. PubMed ID: 29325847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefrontal and Striatal Dopamine Release Are Inversely Correlated in Schizophrenia.
    Frankle WG; Himes M; Mason NS; Mathis CA; Narendran R
    Biol Psychiatry; 2022 Nov; 92(10):791-799. PubMed ID: 35791965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum.
    Narendran R; Mason NS; Laymon CM; Lopresti BJ; Velasquez ND; May MA; Kendro S; Martinez D; Mathis CA; Frankle WG
    J Pharmacol Exp Ther; 2010 May; 333(2):533-9. PubMed ID: 20103586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography study.
    Narendran R; Martinez D; Mason NS; Lopresti BJ; Himes ML; Chen CM; May MA; Price JC; Mathis CA; Frankle WG
    Synapse; 2011 Dec; 65(12):1344-9. PubMed ID: 21780185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET imaging of dopamine-D2 receptor internalization in schizophrenia.
    Weinstein JJ; van de Giessen E; Rosengard RJ; Xu X; Ojeil N; Brucato G; Gil RB; Kegeles LS; Laruelle M; Slifstein M; Abi-Dargham A
    Mol Psychiatry; 2018 Jun; 23(6):1506-1511. PubMed ID: 28507321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine-induced striatal dopamine release in schizotypal personality disorder.
    Thompson JL; Rosell DR; Slifstein M; Xu X; Rothstein EG; Modiano YA; Kegeles LS; Koenigsberg HW; New AS; Hazlett EA; McClure MM; Perez-Rodriguez MM; Siever LJ; Abi-Dargham A
    Psychopharmacology (Berl); 2020 Sep; 237(9):2649-2659. PubMed ID: 32572588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine-induced dopamine release: duration of action as assessed with the D2/3 receptor agonist radiotracer (-)-N-[(11)C]propyl-norapomorphine ([11C]NPA) in an anesthetized nonhuman primate.
    Narendran R; Slifstein M; Hwang DR; Hwang Y; Scher E; Reeder S; Martinez D; Laruelle M
    Synapse; 2007 Feb; 61(2):106-9. PubMed ID: 17117423
    [No Abstract]   [Full Text] [Related]  

  • 9. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal dopamine release in schizophrenia comorbid with substance dependence.
    Thompson JL; Urban N; Slifstein M; Xu X; Kegeles LS; Girgis RR; Beckerman Y; Harkavy-Friedman JM; Gil R; Abi-Dargham A
    Mol Psychiatry; 2013 Aug; 18(8):909-15. PubMed ID: 22869037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.
    Abi-Jaoude E; Segura B; Obeso I; Cho SS; Houle S; Lang AE; Rusjan P; Sandor P; Strafella AP
    Hum Brain Mapp; 2015 Jul; 36(7):2592-601. PubMed ID: 25788222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron-labeled dopamine agonists for probing the high affinity states of dopamine subtype 2 receptors.
    Hwang DR; Narendran R; Laruelle M
    Bioconjug Chem; 2005; 16(1):27-31. PubMed ID: 15656572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-N-[(11)C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D(2) receptors.
    Hwang DR; Kegeles LS; Laruelle M
    Nucl Med Biol; 2000 Aug; 27(6):533-9. PubMed ID: 11056366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
    Slifstein M; van de Giessen E; Van Snellenberg J; Thompson JL; Narendran R; Gil R; Hackett E; Girgis R; Ojeil N; Moore H; D'Souza D; Malison RT; Huang Y; Lim K; Nabulsi N; Carson RE; Lieberman JA; Abi-Dargham A
    JAMA Psychiatry; 2015 Apr; 72(4):316-24. PubMed ID: 25651194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the proportion of D2 receptors configured in state of high affinity for agonists in vivo: a positron emission tomography study using [11C]N-propyl-norapomorphine and [11C]raclopride in baboons.
    Narendran R; Hwang DR; Slifstein M; Hwang Y; Huang Y; Ekelund J; Guillin O; Scher E; Martinez D; Laruelle M
    J Pharmacol Exp Ther; 2005 Oct; 315(1):80-90. PubMed ID: 16014571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals.
    Seeman P
    Synapse; 2009 Mar; 63(3):186-92. PubMed ID: 19086090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET.
    Gallezot JD; Kloczynski T; Weinzimmer D; Labaree D; Zheng MQ; Lim K; Rabiner EA; Ridler K; Pittman B; Huang Y; Carson RE; Morris ED; Cosgrove KP
    Neuropsychopharmacology; 2014 Mar; 39(4):866-74. PubMed ID: 24220025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine.
    Smith CT; Dang LC; Cowan RL; Kessler RM; Zald DH
    Neuropharmacology; 2016 Sep; 108():394-402. PubMed ID: 27174408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophrenia.
    Gevonden M; Booij J; van den Brink W; Heijtel D; van Os J; Selten JP
    JAMA Psychiatry; 2014 Dec; 71(12):1364-72. PubMed ID: 25271822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoflurane anaesthesia differentially affects the amphetamine sensitivity of agonist and antagonist D2/D3 positron emission tomography radiotracers: implications for in vivo imaging of dopamine release.
    McCormick PN; Ginovart N; Wilson AA
    Mol Imaging Biol; 2011 Aug; 13(4):737-46. PubMed ID: 20680481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.